VERTEX PHARMACEUTICALS INC / MA VRTX
출처: SEC EDGAR XBRL companyconcept (10-K) · 통화 USD
검증 ✓ 매출·재무 = SEC EDGAR XBRL companyconcept (10-K) 공시원본 (AI 추정 0) ✓ 재무 신호 = 공시 숫자 계산 (AI 아님)
$3.2B$6.5B$9.7B$13B $12B 20082025
🏭 사업부 흥망 해부도(성장·고전·철수·실패) 펼쳐보기 →
재무 신호 · 공시 숫자 계산 · AI 아님 · 판정 없음
✦ 흥망사
버튼을 누르면 위 공시 숫자에 근거한 흥망사를 생성합니다 — AI 서술, 예측·투자조언 없음.
▾ 데이터 표 보기
연도 매출영업이익순이익자산부채 FCF 영업이익률 매출 YoY
2008 $176M-$463M -$259M -263.6%
2009 $102M-$614M-$642M$2B$859M -$451M -602.6% ▼ 41.9%
2010 $143M-$696M-$755M$1.7B$1.2B -$673M -485.5% ▲ 40.7%
2011 $1.4B$114M$30M$2.2B$1.2B $109M 8.1% ▲ 883.9%
2012 $1.5B$47M-$107M$2.8B$1.5B $197M 3.1% ▲ 8.3%
2013 $1.2B-$610M-$445M$2.3B$963M -$112M -50.3% ▼ 20.6%
2014 $580M-$692M-$739M$2.3B$1.2B -$624M -119.3% ▼ 52.1%
2015 $1B-$467M-$556M$2.5B$1.4B -$411M -45.2% ▲ 77.9%
2016 $1.7B$10M-$112M$2.9B$1.6B $180M 0.6% ▲ 64.9%
2017 $2.5B$123M$263M$3.5B$1.5B $746M 5.0% ▲ 46.2%
2018 $3B$635M$2.1B$6.2B$1.8B $1.2B 20.8% ▲ 22.5%
2019 $4.2B$1.2B$1.2B$8.3B$2.2B $1.5B 28.8% ▲ 36.6%
2020 $6.2B$2.9B$2.7B$11.8B$3.1B $3B 46.0% ▲ 49.1%
2021 $7.6B$2.8B$2.3B$13.4B$3.3B $2.4B 36.7% ▲ 22.1%
2022 $8.9B$4.3B$3.3B$18.2B$4.2B $3.9B 48.2% ▲ 17.9%
2023 $9.9B$3.8B$3.6B$22.7B$5.1B $3.3B 38.8% ▲ 10.5%
2024 $11B-$233M-$536M$22.5B$6.1B -$790M -2.1% ▲ 11.7%
2025 $12B$4.2B$4B$25.6B$7B $3.2B 34.8% ▲ 8.9%